Your browser doesn't support javascript.
loading
Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis.
Funayama, Michitaka; Koreki, Akihiro; Takata, Taketo; Kurose, Shin; Hisamatsu, Tetsuya; Ono, Atsushi; Yagihashi, Tatsuhiko; Mizushima, Jin; Yagi, Yoshikazu; Ogino, Satoyuki; Oi, Hiroki; Mimura, Yu; Shimizu, Yusuke; Kudo, Shun; Nishi, Akira; Mukai, Hiroo.
Afiliação
  • Funayama M; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan. Electronic address: mctkfnym@gmail.com.
  • Koreki A; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, 266-0007, Japan. Electronic address: rohikiakireko@yahoo.co.jp.
  • Takata T; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan. Electronic address: takata_taketo@hotmail.com.
  • Kurose S; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, 266-0007, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 1
  • Hisamatsu T; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Gunma Hospital, Gunma, 370-3516, Japan. Electronic address: dhisamatsu@outlook.com.
  • Ono A; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Fuji Hospital, Fukushima, 960-0811, Japan. Electronic address: noma20060308@major.ocn.ne.jp.
  • Yagihashi T; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Psychiatry, Jichi Medical University, Tochigi, 329-0431, Japan. Electronic address: yagihashi.tatsuhiko@jichi.ac.jp.
  • Mizushima J; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Psychiatry, Tachikawa Hospital, Tokyo, 190-8531, Japan. Electronic address: jtmizushima@gmail.com.
  • Yagi Y; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Ageo Mental Clinic, Saitama, 362-0037, Japan. Electronic address: ageomen@gmail.com.
  • Ogino S; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan. Electronic address: x01ogino@yahoo.co.jp.
  • Oi H; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan; Komagino Hospital, Tokyo, 193-8505, Japan. Electronic address: kyokui090010@gmail.com.
  • Mimura Y; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan. Electronic address: yu.mimura@a3.keio.jp.
  • Shimizu Y; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Mitaka, Tokyo, 181-8611, Japan. Electronic address: yskshimizu0303@icloud.com.
  • Kudo S; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan; Department of Psychiatry, Saitama City Hospital, Saitama, 336-8522, Japan. Electronic address: kudoshun
  • Nishi A; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan. Electronic address: aovestn@gmail.com.
  • Mukai H; Department of Neuropsychiatry, Ashikaga Red Cross Hospital, Ashikaga, Tochigi, 326-0843, Japan; Department of Neuropsychiatry, Keio University School of Medicine, Shinjuku, Tokyo, 160-8582, Japan. Electronic address: mukai.hr@gmail.com.
J Psychiatr Res ; 151: 419-426, 2022 07.
Article em En | MEDLINE | ID: mdl-35597225
ABSTRACT

BACKGROUND:

Although differential diagnosis between autoimmune encephalitis and schizophrenia spectrum disorders is crucial for a good outcome, the psychiatric symptoms that distinguish these two conditions have not been identified even though psychiatric symptoms are often the main manifestation of autoimmune encephalitis. Also, there are many situations in clinical psychiatry in which laboratory testing and imaging studies are not available. Because no comparative study of the psychiatric symptoms between these two conditions has been carried out, we explored diagnostically useful psychiatric symptoms in a retrospective case-control study.

METHODS:

We recruited 187 inpatients with first-episode psychosis who were admitted to our psychiatric unit and categorized them into two groups the autoimmune encephalitis group (n = 10) and the schizophrenia spectrum disorders group (n = 177). Differences in the symptoms and signs between the two groups were investigated.

RESULTS:

Schneider's first-rank symptoms (e.g., verbal commenting hallucinations and delusional self-experience) were observed only in the schizophrenia spectrum disorders group, whereas altered perception was found more frequently in the autoimmune encephalitis group. Functional status was worse in the autoimmune encephalitis group, and neurological and neuropsychological signs were revealed almost exclusively in this group. A history of mental illness was more frequently reported in the schizophrenia spectrum disorders group than in the autoimmune encephalitis group.

CONCLUSIONS:

The psychiatric symptoms, i.e., Schneider's first-rank symptoms and altered perception, together with neurological and neuropsychological signs, functional status, and past history, may help clinicians accurately differentiate these two conditions among patients with first-episode psychosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Encefalite Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos Psicóticos / Esquizofrenia / Encefalite Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Psychiatr Res Ano de publicação: 2022 Tipo de documento: Article
...